Search research articles
Contact Us
Filters
Showing results (61-70 of 153) with videos related to
Page
of 16
Sort By:
The Prostate
|
March 17, 2006
Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7
Christine Mian, Michele Lodde, Evi Comploj, et al.
Journal of Clinical Pathology
|
October 26, 2018
Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer
Carolina D Elia, Alexander Pycha, Decio M Folchini, et al.
Minerva Urology and Nephrology
|
March 18, 2024
Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor
Margherita Palermo, Carolina D'Elia, Emanuela Trenti, et al.
Magnetic Resonance Imaging
|
November 21, 2025
Arterial spin labelling as a contrast-free alternative to dynamic contrast enhancement for the evaluation of peripheral zone prostatic lesions on MRI
Valentina Corato, Vincenzo Vingiani, Bernardo Proner, et al.
The Journal of Pathology
|
September 21, 2004
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer
Barbara Comuzzi, Constanze Nemes, Stefan Schmidt, et al.
Aktuelle Urologie
|
October 27, 2022
[Life-threatening complication caused by a neurostimulator]
Sara Krüger, Stefanie Thaler, Silvia Clauser, et al.
European Urology
|
May 18, 2010
Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours
Christine Mian, Guido Mazzoleni, Silke Vikoler, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 21, 2014
Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading
Michele Lodde, Christine Mian, Roman Mayr, et al.
Urologia Internationalis
|
August 21, 2014
Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study
Atiqullah Aziz, Stephan Madersbacher, Wolfgang Otto, et al.
Anticancer Research
|
August 10, 2002
Correlation of clinical outcome with p53 and p21 status in patients with advanced transitional-cell carcinoma treated with paclitaxel and carboplatin
Maria Flamm, Thomas Brodowicz, Andrea Haitel, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 153) with videos related to
Sort By:
Page
of 16
The Prostate
|
March 17, 2006
Molecular biological analysis of the heterogeneous prostate cancer group Gleason score 7
Christine Mian, Michele Lodde, Evi Comploj, et al.
Journal of Clinical Pathology
|
October 26, 2018
Diagnostic predictive value of Xpert Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer
Carolina D Elia, Alexander Pycha, Decio M Folchini, et al.
Minerva Urology and Nephrology
|
March 18, 2024
Prospective evaluation of the RT-PCR based urinary marker Bladder Epicheck® as a diagnostic tool in upper urinary tract tumor
Margherita Palermo, Carolina D'Elia, Emanuela Trenti, et al.
Magnetic Resonance Imaging
|
November 21, 2025
Arterial spin labelling as a contrast-free alternative to dynamic contrast enhancement for the evaluation of peripheral zone prostatic lesions on MRI
Valentina Corato, Vincenzo Vingiani, Bernardo Proner, et al.
The Journal of Pathology
|
September 21, 2004
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer
Barbara Comuzzi, Constanze Nemes, Stefan Schmidt, et al.
Aktuelle Urologie
|
October 27, 2022
[Life-threatening complication caused by a neurostimulator]
Sara Krüger, Stefanie Thaler, Silvia Clauser, et al.
European Urology
|
May 18, 2010
Fluorescence in situ hybridisation in the diagnosis of upper urinary tract tumours
Christine Mian, Guido Mazzoleni, Silke Vikoler, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 21, 2014
Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading
Michele Lodde, Christine Mian, Roman Mayr, et al.
Urologia Internationalis
|
August 21, 2014
Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study
Atiqullah Aziz, Stephan Madersbacher, Wolfgang Otto, et al.
Anticancer Research
|
August 10, 2002
Correlation of clinical outcome with p53 and p21 status in patients with advanced transitional-cell carcinoma treated with paclitaxel and carboplatin
Maria Flamm, Thomas Brodowicz, Andrea Haitel, et al.
Page
of 16